NMR solution structures of stereoisomeric covalent polycyclic aromatic carcinogen− DNA adducts: principles, patterns, and diversity
NE Geacintov, M Cosman, BE Hingerty… - Chemical research in …, 1997 - ACS Publications
Exogenous chemicals have been implicated in causing mutations that are responsible for
the initiation and progression of tumors (1r5). Mutations in the p53 gene, a tumor suppressor …
the initiation and progression of tumors (1r5). Mutations in the p53 gene, a tumor suppressor …
[HTML][HTML] Factors that influence the mutagenic patterns of DNA adducts from chemical carcinogens
KY Seo, SA Jelinsky, EL Loechler - Mutation Research/Reviews in …, 2000 - Elsevier
Carcinogens are generally mutagens, which is understandable given that tumor cells grow
uncontrollably because they have mutations in critical genes involved in growth control …
uncontrollably because they have mutations in critical genes involved in growth control …
Targeting of lung cancer mutational hotspots by polycyclic aromatic hydrocarbons
LE Smith, MF Denissenko, WP Bennett… - Journal of the …, 2000 - academic.oup.com
Abstract Background: Polycyclic aromatic hydrocarbons (PAHs) are ubiquitous in
combustion products of organic matter, including cigarette smoke. Metabolically activated …
combustion products of organic matter, including cigarette smoke. Metabolically activated …
Error-prone lesion bypass by human DNA polymerase η
Y Zhang, F Yuan, X Wu, O Rechkoblit… - Nucleic acids …, 2000 - academic.oup.com
DNA lesion bypass is an important cellular response to genomic damage during replication.
Human DNA polymerase η (Polη), encoded by the Xeroderma pigmentosum variant (XPV) …
Human DNA polymerase η (Polη), encoded by the Xeroderma pigmentosum variant (XPV) …
Nucleotide excision repair eliminates unique DNA-protein cross-links from mammalian cells
DJ Baker, G Wuenschell, L Xia, J Termini… - Journal of Biological …, 2007 - ASBMB
DNA-protein cross-links (DPCs) present a formidable obstacle to cellular processes
because they are" superbulky" compared with the majority of chemical adducts. Elimination …
because they are" superbulky" compared with the majority of chemical adducts. Elimination …
Translesion Synthesis by Human DNA Polymerase κ on a DNA Template Containing a Single Stereoisomer of dG-(+)- or dG-(−)-anti-N2-BPDE (7,8-Dihydroxy-anti-9,10-epoxy …
N Suzuki, E Ohashi, A Kolbanovskiy, NE Geacintov… - Biochemistry, 2002 - ACS Publications
Several recently discovered human DNA polymerases are associated with translesion
synthesis past DNA adducts. These include human DNA polymerase κ (pol κ), a homologue …
synthesis past DNA adducts. These include human DNA polymerase κ (pol κ), a homologue …
Characteristics of mutations in the p53 gene in oral squamous cell carcinoma associated with betel quid chewing and cigarette smoking in Taiwanese
LL Hsieh, PF Wang, IH Chen, CT Liao… - …, 2001 - academic.oup.com
Abstract p53 mutations are etiologically associated with the development of oral squamous
cell carcinomas (OSCCs) or are associated with exposure to specific carcinogens. In this …
cell carcinomas (OSCCs) or are associated with exposure to specific carcinogens. In this …
Biological properties of single chemical− DNA adducts: a twenty year perspective
JC Delaney, JM Essigmann - Chemical research in toxicology, 2008 - ACS Publications
The genome and its nucleotide precursor pool are under sustained attack by radiation,
reactive oxygen and nitrogen species, chemical carcinogens, hydrolytic reactions, and …
reactive oxygen and nitrogen species, chemical carcinogens, hydrolytic reactions, and …
Activities of human DNA polymerase κ in response to the major benzo [a] pyrene DNA adduct: error-free lesion bypass and extension synthesis from opposite the …
Y Zhang, X Wu, D Guo, O Rechkoblit, Z Wang - DNA repair, 2002 - Elsevier
In cells, the major benzo [a] pyrene DNA adduct is the highly mutagenic (+)-trans-anti-BPDE-
N2-dG. In eukaryotes, little is known about lesion bypass of this DNA adduct during …
N2-dG. In eukaryotes, little is known about lesion bypass of this DNA adduct during …
DNA adducts, mutations, and cancer 2000
K Hemminki, M Koskinen, H Rajaniemi… - Regulatory toxicology and …, 2000 - Elsevier
The main achievements in the DNA adduct field in the 1990s have been technical
innovations of methods for specific adducts reaching sensitivities required for low levels …
innovations of methods for specific adducts reaching sensitivities required for low levels …